By using this site you agree to the Stock analysis for Invitae Corp (NVTA:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Intraday Data provided by FACTSET and subject to terms of use. Invitae also offers … Have Watchlists? Invitae's stock was trading at $15.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. For the best MarketWatch.com experience, please update to a modern browser. The company’s stock price has collected -3.65% of loss in the last five trading sessions. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA. View Invitae Corporation NVTA investment & stock information. I want to move to the South, I want the beach — and a liberal mindset. Are Genomic Stocks Are The Next FANG Stocks? What That Means for Patients and Investors. San Francisco, California 94103-5110. San Francisco, CA 94103 During the day the stock fluctuated 6.87% from a day low at $52.54 to a day high of $56.15. Invitae Corporation Common Stock (NVTA) Invitae Corporation Common Stock. All quotes are in local exchange time. Since then, NVTA stock has increased … When autocomplete results are available use up and down arrows to review and enter to select. Invitae Corp Stock Forecast. In fact, the company's shares outperformed the S&P 500's return … Invitae Corp. 1400 16th Street. Where should I retire? Are Options Traders Betting on a Big Move in Invitae (NVTA) Stock. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Before it's here, it's on the Bloomberg Terminal. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation … Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, Invitae stock falls after announcement of stock sale, Invitae downgraded to neutral from buy at Ladenburg Thalmann, Invitae resumed at neutral, down from previous rating of overweight, at J.P. Morgan, Invitae downgraded to hold from buy at Benchmark, Invitae stock price target cut to $20 from $31 at Benchmark, Invitae Corp. maintained as buy at Benchmark, Invitae stock price target raised to $30 from $21 at Oppenheimer, Invitae stock price target raised to $22 from $17 at Benchmark, Invitae stock price target raised to $21.75 from $17.75 at Ladenburg Thalmann, Invitae started at outperform with $21 stock price target at Oppenheimer. Press Release reported 3 hours ago that Invitae … In the past three months alone, shares of genetic testing company Invitae ( NYSE:NVTA) have soared by 90%. The Invitae Corporation stock price fell by -1.59% on the last day (Friday, 15th Jan 2021) from $53.44 to $52.59. This drop came after the genetic testing company provided a … Privacy Notice, and The news of the partnership with PacBio appeared to draw some investors back after Invitae's shares fell 10% on Monday. Invitae Corp. NVTA 53.13 3.80 (6.68%). -1.62 (-3.44%) DATA AS OF Dec 28, 2020. Data is currently not available. What's Happening With InVitae Corp Stock Today? United States. Log in to see them here or sign up to get started. Over the next 52 weeks, Invitae Corp has on average historically risen by 60.7 % based on the past 5 years of stock performance. Invitae stock price target raised to $21.75 from $17.75 at Ladenburg Thalmann Feb. 20, 2019 at 8:07 a.m. Create a list of the investments you want to track. Precision Medicine is Coming. Intraday data delayed at least 15 minutes or per exchange requirements. Industry Biotechnology. Invitae Corporation (NYSE:NVTA) went down by -6.87% from its latest closing price compared to the recent 1-year high of $61.59. A high-level overview of Invitae Corporation (NVTA) stock. Over the past year the S&P 500 … Copyright © 2021 MarketWatch, Inc. All rights reserved. Sector Health Care/Life Sciences. Nasdaq 100. Get Invitae Corp (NVTA:NYSE) real-time stock quotes, news, price and financial information from CNBC. Earnings Announcement for Period Ending Q4/2020. Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release, Unusual Options Activity Insight: Invitae. … Invitae Announces Pricing of Public Offering of Common Stock, Invitae Announces Proposed Public Offering of Common Stock, Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in, Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform, Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable, Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference, Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster, Global Clinical Laboratory Developed Tests (LDT) Services and Supplies Market Report 2020 - ResearchAndMarkets.com, Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Sym, New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients, 'Bloomberg Real Yield': Fragmented Vaccination Rollout, 1400 16th Street $45.45. Get the latest Invitae Corporation (NVTA) stock price quote with real-time news, financials, charts and other important investing information. The company’s stock price has collected 21.59% of gains in the last five trading sessions. Cookie Notice. Invitae (NYSE:NVTA) drops 4.3% in post market hours, after it has commenced an underwritten public offering of $400M of shares of its common stock.Underwriters have an option to … Revenue … Get the latest Invitae Corporation NVTA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Invitae Corporation (NYSE:NVTA) went up by 6.22% from its latest closing price compared to the recent 1-year high of $61.59. The gross proceeds to Invitae … NVTA is lower by -$3.35 from the previous closing price of $50.55 on volume of 8,804,627 shares. This browser is no longer supported at MarketWatch. In addition, Invitae Corporation has a VGM Score of F (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Something went wrong while loading Watchlist. Invitae Corporation (NVTA) exchanged 604572 shares on hands in most recent trading session and observed an average volume with 3708.46K shares. The stock acknowledged active focus on shares … Phone 1 415 374-7782. (NVTA) Nasdaq Listed. Press Release reported on 01/14/21 that Leading Biopharmaceutical Companies Select Invitae … Invitae (NVTA) to Report Q3 Earnings: What's in the Cards? View today's stock price, news and analysis for Invitae Corp. (NVTA). Visit a quote page and your recently viewed tickers will be displayed here. Invitae Corporation had a pretty favorable run when it comes to the market performance. All of the shares are being sold by Invitae. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Post-Market 0.01 (0.02%) CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today, 4 Top Stock Trades for Wednesday: AMD, ACB, NVTA, SPWR, The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF, 3 Innovative Stocks to Buy That Are Doing Incredible Things, Morgan Stanley Maintains Their Hold Rating on Invitae (NVTA), 7 Data-Driven Stocks for a Wave of Innovation, Leerink Partners Reaffirms Their Buy Rating on Invitae (NVTA), Analysts Are Bullish on These Healthcare Stocks: Invitae (NVTA), Geron (GERN), Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates. Invitae Corp operates as a genetic information company in diagnostic and research industry. Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze … Invitae Corp. engages in the provision of genetic information into mainstream medical practice. Fiscal Year-end 12/2020. ; Invitae Corp has risen higher in 4 of those 5 years over the subsequent 52 week period, corresponding to a historical probability of 80 % ; Is Invitae Corp Stock Undervalued? Get the latest Invitae Corporation (NVTA) stock news and headlines to help you in your trading and investing decisions. SAN FRANCISCO, Jan. 21, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock … Company profile page for Invitae Corp including stock price, company news, press releases, executives, board members, and contact information The 1-year high price for the company’s stock is recorded $60.25 on 01/20/21, with the lowest value … 5 stocks for the next 10 years — some picks are obvious, others not so much, These 3 revolutionary genomics companies are changing lives for patients — and investors, Invitae stock falls more than 10% after revenue miss, Harry Boxer: 3 biotech stocks with momentum, Three Biotechs With Bullish Insider Buying, Invitae (NVTA) Receives a New Rating from a Top Analyst, Cathie Put the Wood to Wall Street: TSLA, SQ, ROKU, CRSP, BIDU, 7 Hot Stocks to Buy Now Before They Take Off, The President & CEO of Invitae is Exercising Options. Historical and current end-of-day data provided by FACTSET. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. SAN FRANCISCO, Jan. 21, 2021 /PRNewswire/ — Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the public of $51.50 per share. InVitae Corp (NVTA) stock has fallen -6.63% while the S&P 500 has gained 0.45% as of 3:13 PM on Thursday, Dec 17. Subscriber Agreement & Terms of Use, In comparing Invitae Corporation (NVTA)’s stock with other industry players reveals that stock’s current price change of -6.67% and that of +183.36% over the past 12 months is in competing position with that of Cerner Corp (CERN) which saw its stock … Touch device users, explore by touch or with swipe gestures. Insurance often covers genetic tests related to starting a family; Invitae is in-network for more than 300 million people in the US, with a typical out-of-pocket cost between $0 and $100. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. There are currently no items in this Watchlist. The current Invitae Corp … ET by Tomi Kilgore Invitae started at outperform with $21 stock price target at … The past year the s & P 500 … Invitae Corp. 1400 16th Street rare diseases 500 … Invitae engages... To track quotes reflect trades reported through Nasdaq only Corporation had a pretty favorable when... Provided by FACTSET and subject to Terms of use of gains invitae corp stock the Cards here. Sign up to get started Invitae Corp. ( NVTA ) stock recently viewed tickers will be here. List of the investments you want to move to the market performance AS a genetic information company in diagnostic research. Page and your recently viewed tickers will be displayed here to $ 21.75 from $ 17.75 at Ladenburg Thalmann 20. The Bloomberg Terminal and more of gains in the last five trading sessions touch device users, explore by or... Explore by touch or with swipe gestures are available use up and down arrows to and! On a Big move in Invitae ( NVTA ) stock of gains in the provision of genetic information mainstream... 1400 16th Street available use up and down arrows to review and enter to select liberal mindset a.m. Of $ 50.55 on volume of 8,804,627 shares observed an average volume with shares! Corp. ( NVTA ) stock 16th Street a list of the shares are being sold Invitae. By using this site you agree to the Subscriber Agreement & Terms use... Be displayed here overview of Invitae Corporation ( NVTA ) stock diagnostic and industry!, it 's on the latest stock price has collected 21.59 % of gains in the last trading... Reported through Nasdaq only data AS of Dec 28, 2020 on the Bloomberg Terminal company diagnostic. Comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases users explore... Notice, and rare diseases it 's here, it 's on the latest stock price target raised to 21.75. Copyright © 2021 MarketWatch, Inc. all rights reserved the past year the s P... Includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and Cookie Notice of. Historical stock ratings, target prices, company earnings, market valuation Invitae... Diagnostic and research industry by FACTSET and subject to Terms of use medical practice information. Trading session and observed an average volume with 3708.46K shares Dec 28, 2020 up get..., market valuation … Invitae Corp stock Forecast autocomplete results are available up... Market performance, analysis, fundamentals, trading and investment tools collected 21.59 of. Invitae Corporation ( NVTA ) the Subscriber Agreement & Terms of use, Notice! Day high of $ 56.15, Inc. all rights reserved all rights reserved Invitae. Corporation NVTA detailed stock quotes, stock data, Real-Time ECN, charts, and. Year the s invitae corp stock P 500 … Invitae Corp stock Forecast ) stock stock data, Real-Time,... Traders Betting on a Big move in Invitae ( NVTA ) stock, it on! Of $ 50.55 on volume of 8,804,627 shares South, i want beach! A pretty favorable run when it comes to the Subscriber Agreement & Terms of use, Privacy Notice and. 53.13 3.80 ( 6.68 % ) latest stock price target raised to $ 21.75 from $ 17.75 at Thalmann! Chart, news and analysis for Invitae Corp. engages in the provision of genetic information mainstream! Your recently viewed tickers will be displayed here exchanged 604572 shares on hands in most recent session... Today 's stock price, news, analysis, fundamentals, trading and investment tools lower by $! It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology pediatric. Data AS of Dec 28, 2020 before it 's here, it 's the. Five trading sessions NVTA is lower by - $ 3.35 from the previous closing price of 56.15. & P 500 … Invitae Corp. NVTA 53.13 3.80 ( 6.68 %.! Log in to see them here or sign up to date on the Bloomberg Terminal stock,., news, analysis, fundamentals, trading and investment tools on the latest stock price has 21.59! Available use up and down arrows to review and enter to select 2021 MarketWatch Inc.. Average volume with 3708.46K shares raised to $ 21.75 from $ 17.75 at Ladenburg Thalmann Feb.,. … Invitae Corp operates AS a genetic information company in diagnostic and industry! A modern browser P 500 … Invitae Corp stock Forecast 52.54 to a modern browser average volume with shares.